Toll like receptor agonist effects on human CD8+ T cell activation and expression of T cell checkpoint receptors. [PDF]
Jeon D, Moseman JE, Hill E, McNeel DG.
europepmc +1 more source
PBRM1 ranks as the second most commonly mutated gene in ccRCC. This study reveals that PBRM1 loss promotes an immunosuppressive microenvironment by elevating M2 TAMs via the KDM5C–IL‐6 axis. These M2 TAMs, along with CAFs, form a barrier that excludes CD8+ T cells. Targeting IL‐6 synergizes with anti‐PD1 therapy, offering a promising strategy for PBRM1‐
Wenjiao Xia +14 more
wiley +1 more source
Comparative analysis of malignant pleural effusion and peripheral blood reveals unique T cell signatures associated with survival in mesothelioma patients. [PDF]
Principe N +17 more
europepmc +1 more source
Intravital imaging of the formation and resolution of MHC class II-positive T-cell activation niches. [PDF]
Oleksyn D, Miller J.
europepmc +1 more source
Terminally exhausted CD8<sup>+</sup> T cells in solid tumors: biology, biomarker potential and translational tools for precision oncology. [PDF]
Guo X, Ma S, Wang J, Fu Y, Ma W.
europepmc +1 more source
CXCR6 promotes dermal CD8+ T cell survival and transition to long-term tissue residence. [PDF]
Heim TA +6 more
europepmc +1 more source
LSD1 Inhibition Induces MHC-I and Dendritic Cell Activation to Promote Antitumor Immunity in Head and Neck Squamous Cell Carcinoma. [PDF]
Chakraborty AK +9 more
europepmc +1 more source
Possible Involvement of Skin-Resident Memory T Cells in Refractory Chronic Alopecia Areata. [PDF]
Kageyama R +4 more
europepmc +1 more source

